GINMU >
01 奈良県立医科大学 >
012 大学院 >
0122 学位請求論文 >
01221 博士論文(医学) >
2015年度 >
このアイテムの引用には次の識別子を使用してください:
http://hdl.handle.net/10564/3072
|
タイトル: | Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma. |
その他のタイトル: | ヒト肝細胞癌においてherpesvirus entry mediatorの発現がもたらす影響 |
著者: | Hokuto, Daisuke Sho, Masayuki![](/dspace/image/metalink/link_ja.gif) Yamato, Ichiro![](/dspace/image/metalink/link_ja.gif) Yasuda, Satoshi Obara, Shinsaku Nomi, Takeo![](/dspace/image/metalink/link_ja.gif) Nakajima, Yoshiyuki![](/dspace/image/metalink/link_ja.gif) |
キーワード: | HVEM HCC TIL Prognosis Tumour immunity TNFRSF14 |
発行日: | 2015年1月 |
出版者: | Elsevier |
引用: | European journal of cancer Vol.51 No.2 p.157-165(2015.01) |
抄録: | BACKGROUND:
Herpes virus entry mediator (HVEM), also known as tumour necrosis factor receptor (TNFR) superfamily 14, regulates a variety of physiological and pathological responses in both innate and acquired immunity. Although HVEM is also suggested to be a critical regulator in tumours, actual roles in human cancer are largely unknown. This study aimed to clarify clinical importance of HVEM in human hepatocellular carcinoma (HCC).
PATIENTS AND METHODS:
We studied HVEM expression in 150 HCC patients to explore its clinical relevance, and we examined tumour infiltrating T cells and local immune status of them.
RESULTS:
HVEM was expressed in HCC cells, while no or only limited expression was observed in normal tissues in the liver. Tumour HVEM expression was significantly correlated with age, serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) level, vascular invasion and tumour node metastasis (TNM) stage. Furthermore, tumour HVEM expression significantly correlated with postoperative recurrence and survival. Importantly, multivariate analysis indicated that the HVEM status had an independent prognostic value. Furthermore, HVEM status was inversely correlated with tumour-infiltrating CD4(+), CD8(+) and CD45RO(+) lymphocytes. In addition, it was also associated with reduced expression of perforin, granzyme B and interferon-γ (IFN-γ). Taken together, tumour-expressing HVEM plays a functionally important role in HCC.
CONCLUSION:
Tumour-expressing HVEM plays a critical role in human HCC, possibly through regulating immune evasion. Therefore, targeting HVEM may be a novel promising therapeutic strategy for HCC. |
内容記述: | 博士(医学)・乙第1359号・平成27年5月28日 Copyright © 2014 Elsevier Ltd. |
URI: | http://hdl.handle.net/10564/3072 |
ISSN: | 09598049 |
DOI: | http://dx.doi.org/10.1016/j.ejca.2014.11.004 |
学位授与番号: | 24601B1359 |
学位授与年月日: | 2015-05-28 |
学位名: | 博士(医学) |
学位授与機関: | 奈良県立医科大学 |
出現コレクション: | 2015年度
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|